NASDAQ: CPRXCatalyst Pharmaceuticals Inc Stock Ownership - Who owns Catalyst Pharmaceuticals?
Insider buying vs selling
Have Catalyst Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Molly Harper | Director | 2025-12-12 | 15,527 | $23.20 | $360.20kSell |
| Molly Harper | Director | 2025-12-12 | 6,746 | $23.06 | $155.56kSell |
| Molly Harper | Director | 2025-12-12 | 4,473 | $23.73 | $106.16kSell |
| Molly Harper | Director | 2025-12-12 | 20,000 | $5.78 | $115.60kBuy |
| Carmen Jeffrey Del | Chief Commercial Officer | 2025-11-26 | 10,983 | $4.21 | $46.24kBuy |
| Carmen Jeffrey Del | Chief Commercial Officer | 2025-11-26 | 10,983 | $23.33 | $256.24kSell |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-11-12 | 40,000 | $22.70 | $908.00kSell |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-08 | 30,000 | $20.30 | $609.00kSell |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-08 | 112,475 | $2.24 | $251.94kBuy |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-04 | 30,000 | $2.24 | $67.20kBuy |
CPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CPRX insiders and whales buy or sell their stock.
CPRX Shareholders
What type of owners hold Catalyst Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 14.82% | 18,216,060 | $455.40M | Institution |
| Vanguard Group Inc | 7.09% | 8,713,520 | $217.84M | Institution |
| Biomarin Pharmaceutical Inc | 5.42% | 6,666,667 | $166.67M | Insider |
| State Street Corp | 5.21% | 6,405,387 | $160.13M | Institution |
| Deerfield Management Company LP | 4.05% | 4,974,767 | $124.37M | Institution |
| Patrick J. McEnany | 3.75% | 4,609,324 | $115.23M | Insider |
| Hubert E. Md Huckel | 3.09% | 3,793,238 | $94.83M | Insider |
| Renaissance Technologies LLC | 2.88% | 3,544,830 | $88.62M | Institution |
| Fundsmith LLP | 2.74% | 3,363,807 | $84.10M | Institution |
| Geode Capital Management LLC | 2.35% | 2,890,320 | $72.26M | Institution |
CPRX vs Biotech Stocks
Catalyst Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.